Advancements in Targeted Therapy for Untreatable Glioblastoma
TL;DR
Researchers in Massachusetts are testing an experimental therapy called CAN-3110, which uses a genetically modified herpes simplex virus to provoke an immune response against brain cancer cells. The treatment, injected into the tumor, aims to activate the patient's own immune cells to fight off the cancer. Initial results from a Phase I study showed that even patients with existing antibodies to herpes experienced an enhanced immune response. Further studies are needed to determine the effectiveness of CAN-3110, especially in patients without existing herpes antibodies.
Topics:healthmedical-research#brain-cancer#experimental-therapy#genetically-modified-virus#herpes-virus#immune-response#medical-research
- Experimental therapy fights untreatable brain cancer with genetically modified HERPES virus Daily Mail
- mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma Phys.org
- Researchers design gene therapy that can effectively target glioblastoma Medical Xpress
- An ‘exciting’ glioblastoma study: Boston researchers create virus that can effectively target the aggressive brain cancer Boston Herald
- Clinical trial links oncolytic immunoactivation to survival in glioblastoma Nature.com
Want the full story? Read the original reporting
Read on Daily Mail